Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Anti-tumor activity of temsirolimus in papillary renal cell cancer
No-Receipt date
2015-02052 - 15/07/2015
No-Filing date
20150401480 - 15/07/2015
No-Granting date
3086544 - 21/07/2015
No-EPO application date
08742616.9 - 08/04/2008
No-EPO granting date
2144611 - 17/06/2015
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
7/2015 - 01/09/2015
Expiration date
09/04/2028
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US922759 P10/04/2007/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61P 35/00
A61K 31/436
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1547461
WYETH LLC
66 HUDSON BOULEVARD EAST
NEW YORK, NY 10001-2192
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
1485424
DUKART, GARY
1485425
GIBBONS, JAMES, JOSEPH, JR.
1485426
BERKENBLIT, ANNA
1485427
FEINGOLD, JAY, MARSHALL
Representatives
Code
Firstname
Surname
Address
Town
Zip
1349
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
24/07/2023
Αλλαγή Διεύθυνσης Δικαιούχου (7e800)
ΑΡ.ΠΡΩΤ. 17670/2023 (ΑΡ.ΥΠΟΘ. 4717825/2023) ΔΝΥ. 1628 ΚΩΔ.ΠΛΗΡ. 3463 Η ΕΤΑΙΡΕΙΑ ΑΛΛΑΞΕ ΔΙΕΥΘΥΝΣΗ
612556 Wyeth LLC 235 East 42nd Street ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ New York, NY 10017-5755
1547461 Wyeth LLC 66 Hudson Boulevard East ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ New York, NY 10001-2192
Title Instruments
Payments history
18 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).